In the last decade, the healthcare sector has witnessed one of the most profound transformations. The reason behind this is the constant evolution and introduction of advanced technologies, like generative artificial intelligence (Gen AI). Every stakeholder of this industry is leveraging this technology in their own way. As a result, the overall quality of healthcare being provided to patients is being improved significantly. One key sub-sector that is actively participating in this revolution is pharma. Key application areas of gen AI in the pharma industry include:
Drug discovery and design
The traditional process followed by drug discovery used to be time-consuming and significantly costlier. Apart from this, the average rate of failure also used to be high. But with gen AI, this paradigm is going through a shift. Gen AI can accelerate the identification of novel drug candidates, as there is no need to rely on fixed algorithms.
Clinical trial optimization
This is another important intersection of generative AI pharma and the healthcare market. Designing a clinical trial is an extensive process, as it involves multiple steps, such as performing preclinical research, protocol development, data collection and monitoring and final reporting. When done conventionally, this can take a significant amount of time. Additionally, there is always a chance of patient drop-offs, further delaying the market launch of a new drug or treatment plan. But generative AI pharma can make things a lot easier for companies by simplifying each and every step. From authoring protocols to managing trial data, there is a lot that you can do with the help of this revolutionary technology. It can also produce synthetic data that can be deployed to predict when patients may drop out of a clinical trial.
Regulatory compliance
Ensuring regulatory compliance is one of the most important steps of launching any new product or service in the healthcare market. Gen AI can do so many things to help with the same. It can summarize vast datasets, manage regulatory intelligence and generate compliant content for labels. Additionally, it can also be used to automate compliance checks, which minimizes the chances of any kind of delays in regulatory submissions.
Harnessing real-world evidence
Real-world evidence (RWE) is slowly becoming a crucial requirement in the pharmaceutical industry. It helps in determining how a drug or treatment plan performs outside controlled clinical trials and routine clinical practice. This information adds value at every stage of the product life cycle. It not only supports regulatory submissions but also helps in demonstrating the overall effectiveness and safety of a drug. Gen AI can prove to be very useful in collecting this data.
Data moats
Data moats refer to exclusive data collected by an organization to improve its offering and is very difficult to replicate. This allows organizations to gain a competitive advantage in the market. Generative AI for marketing can also be used to leverage and set up data moats.
The impact of gen AI on the pharmaceutical industry is huge and multifaceted. From faster drug discovery to optimized clinical trials and better regulatory compliance, the list of benefits goes on. When used smartly, this technology can prove to be a game changer for businesses operating in this landscape.
